PTC Stock Recent News

WARREN, N.J. , March 28, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on March 24, 2025, the company approved non-statutory stock options to purchase an aggregate of 12,000 shares of its common stock and 28,220 restricted stock units ("RSUs"), each representing the right to receive one share of its common stock upon vesting, to 35 new employees.

PTC launches Codebeamer 3.0 to speed up product development, boost sustainability and ensure quality and compliance with full traceability and smarter tools.

PTC Therapeutics said on Friday the European Commission will remove its inherited progressive muscle-wasting disorder from the region after an advisory panel reaffirmed a negative opinion of the drug in January.

WARREN, N.J. , March 28, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the European Commission (EC) has adopted the opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) to not renew the authorization of Translarna™ (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy.

Industry-leading ALM solution delivers enhanced speed and scalability with variant management Modern branching method and scaled working sets enable customers to accelerate development of products and ensure compliance Sustainability Template offers eco-friendly design best practices and reduces physical prototypes through reuse Provides end-to-end traceability and process support for product compliance in regulated industries BOSTON , March 27, 2025 /PRNewswire/ --  PTC (NASDAQ: PTC) today announced the release of its Codebeamer® 3.0 Application Lifecycle Management (ALM) solution, designed to enable companies to develop products faster, more sustainably, and with higher quality, as well as help ensure regulatory compliance. Faster: Codebeamer 3.0 introduces a modern branching method and scaled working sets that simplify collaboration between engineering teams and enable them to reduce overall development time.

PTC basically offers end-to-end software solutions for managing the product lifecycle across diverse industries. Their flagship platforms are Windchill, Codebeamer, ServiceMax, and Creo, which overall help with operational efficiency and quality improvements. PTC is also quickly transitioning toward cloud-native SaaS tools. Good examples of this are their Onshape and Arena new offerings.

PTC will unveil Windchill AI, Codebeamer AI and ServiceMax AI at Hannover Messe 2025, promising innovation and fostering digital transformation.

PTC to preview Windchill AI and Document Vault AI agent PTC to demonstrate agentic AI across the product digital thread with Windchill AI, Codebeamer AI, and ServiceMax AI PTC demonstrations available in Hall 17, Stand D40 from March 31 – April 4, 2025 BOSTON , March 25, 2025 /PRNewswire/ -- PTC (NASDAQ: PTC) will preview its Windchill® AI product lifecycle management (PLM) assistant, a generative AI-powered PLM offering, at Hannover Messe 2025. Windchill AI leverages all product data stored in Windchill to enable engineers to access information, make decisions, and develop their products more efficiently.

— Results show 97% of phenylalanine (Phe) tolerance study participants were able to increase their dietary Phe intake with a mean increase of 126% — — Genetic variant analysis of Phase 3 APHENITY trial demonstrates meaningful effect in classical subjects with non-BH4 responsive genotypes — WARREN, N.J. , March 20, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today shared new data being presented from the Phase 3 APHENITY trial and subsequent open-label extension study at the 2025 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting.

BOSTON , March 13, 2025 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that it has appointed Trac Pham to its Board of Directors, effective March 17, 2025. Pham is the former Chief Financial Officer of Synopsys, a recognized leader in electronic design automation and semiconductor development.